Literature DB >> 8698242

Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.

C Y Liu1, A Flesken-Nikitin, S Li, Y Zeng, W H Lee.   

Abstract

BRCA1 is proposed to be a tumor suppressor gene. To explore the biological function of BRCA1, a partial deletion (amino acids 300-361) of mouse Brca1 exon 11 was introduced into the genome of embryonic stem (ES) cells by homologous recombination. Mice carrying one mutated allele of Brca1 appear normal and are fertile up to 10 months of age without any sign of illness. However, no viable progeny homozygous for the Brca1 mutant allele were obtained. Detailed analysis of large numbers of embryos at different stages of development indicated that the homozygous mutant concepti are severely retarded in growth as early as embryonic day 4.5 (E4.5) and are resorbed completely by E8.5. Although the homozygotes at E5.5-E6.5 are able to synthesize DNA and display distinguishable embryonic and extraembryonic structures, they fail to differentiate and form egg cylinders. Consequently, they were unable to form primitive streaks and undergo gastrulation. Consistent with these in vivo results, blastocysts homozygous for mutated Brca1 alleles are at a considerable disadvantage when grown in vitro. These observations suggest that Brca1 has an important role in the early development of mouse embryos.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698242     DOI: 10.1101/gad.10.14.1835

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  84 in total

1.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1.

Authors:  Y F Hu; Z L Hao; R Li
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

3.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Direct DNA binding by Brca1.

Authors:  T T Paull; D Cortez; B Bowers; S J Elledge; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.

Authors:  V Abkevich; A Zharkikh; A M Deffenbaugh; D Frank; Y Chen; D Shattuck; M H Skolnick; A Gutin; S V Tavtigian
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

6.  Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

Authors:  David E Goldgar; Douglas F Easton; Amie M Deffenbaugh; Alvaro N A Monteiro; Sean V Tavtigian; Fergus J Couch
Journal:  Am J Hum Genet       Date:  2004-08-02       Impact factor: 11.025

Review 7.  Haploinsufficiency in mouse models of DNA repair deficiency: modifiers of penetrance.

Authors:  Diane C Cabelof
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

8.  RINT-1 serves as a tumor suppressor and maintains Golgi dynamics and centrosome integrity for cell survival.

Authors:  Xiaoqin Lin; Chang-Ching Liu; Qing Gao; Xiaohai Zhang; GuiKai Wu; Wen-Hwa Lee
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

9.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.

Authors:  David E Goldgar; Douglas F Easton; Graham B Byrnes; Amanda B Spurdle; Edwin S Iversen; Marc S Greenblatt
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.